|
Market Closed -
Nasdaq
21:00:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.110 USD | -5.45% |
|
-2.60% | -30.84% |
| Market Cap | 256M 221M 208M 189M 354M 24.39B 356M 2.46B 951M 12.43B 963M 942M 39.37B | P/E 2026 * |
-1.78x | P/E 2027 * | -1.98x |
|---|---|---|---|---|---|
| Enterprise Value | 226M 195M 183M 167M 313M 21.53B 314M 2.17B 840M 10.97B 850M 831M 34.75B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | -0.99x |
| Free-Float |
85.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
CBOE
| TRDA | Real-time |
Last Transcript : Entrada Therapeutics, Inc.
| 20/12/22 | Nipte winst op Wall Street | |
| 20/12/22 | Wall Street licht hoger | |
| 20/12/22 | Wall Street richting rode opening |
| 1 day | -5.45% | ||
| 1 week | -2.60% | ||
| Current month | +0.85% | ||
| 1 month | +3.49% | ||
| 3 months | +11.62% | ||
| 6 months | -44.02% | ||
| Current year | -30.84% |
| 1 week | 6.94 |  | 7.7 |
| 1 month | 6.76 | | 7.79 |
| Current year | 5.63 | | 16.45 |
| 1 year | 5.02 | | 16.45 |
| 3 years | 4.93 | | 21.79 |
| 5 years | 4.93 | | 36.85 |
| 10 years | 4.93 | | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 31/07/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 31/10/2020 |
Nathan Dowden
PSD | President | 56 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 31/07/2017 |
Kush Parmar
CHM | Chairman | 45 | 30/11/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 30/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% | |
| 03/09/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% | |
| 02/09/26 | Tax | Chief Executive Officer | -8,724 | 0.0224% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.45% | -2.60% | +38.33% | -50.11% | 271M | |
| -0.94% | -0.71% | +45.60% | +103.25% | 69.19B | |
| -0.07% | -3.93% | +32.54% | +78.50% | 62.97B | |
| +3.13% | +1.71% | -12.50% | +390.48% | 27.27B | |
| -3.15% | -6.71% | +25.80% | +10.77% | 25.8B | |
| -0.54% | -5.47% | -3.88% | -18.31% | 24.78B | |
| -1.43% | -1.89% | +21.32% | -19.01% | 20.11B | |
| -4.27% | +3.07% | +211.22% | +362.48% | 18.47B | |
| -1.46% | -4.75% | -5.45% | +505.89% | 14.88B | |
| +1.14% | -0.34% | +52.38% | +163.82% | 14.29B | |
| Average | -1.32% | -0.98% | +40.53% | +152.78% | 27.8B | |
| Weighted average by Cap. | -0.70% | -1.33% | +37.55% | +139.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.89M 11.96M 11.26M 10.26M 19.19M 1.32B 19.27M 133M 51.56M 674M 52.17M 51.04M 2.13B | 22.86M 19.67M 18.52M 16.88M 31.58M 2.18B 31.7M 220M 84.84M 1.11B 85.84M 83.97M 3.51B |
| Net income | -173M -149M -140M -128M -239M -16.49B -240M -1.66B -643M -8.4B -651M -637M -26.62B | -182M -157M -148M -135M -252M -17.35B -253M -1.75B -677M -8.84B -685M -670M -28.01B |
| Net Debt | -30.12M -25.92M -24.41M -22.24M -41.61M -2.87B -41.77M -289M -112M -1.46B -113M -111M -4.63B | -279M -240M -226M -206M -385M -26.56B -387M -2.68B -1.04B -13.53B -1.05B -1.03B -42.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$7.110 | -5.45% | 382,043 |
| 08/09/26 | US$7.520 | +5.47% | 514,213 |
| 04/09/26 | US$7.130 | -0.56% | 341,729 |
| 03/09/26 | US$7.170 | -1.78% | 395,559 |
| 02/09/26 | US$7.300 | +3.25% | 306,542 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
